Autoprocessing and self-activation of the secreted protease CPAF in Chlamydia-infected cells

Microbial Pathogenesis

Volumn 49, Issue 4, 2010, Pages 164-173

  Chen, Ding ^a   Lei, Lei ^a   Flores, Rhonda ^a   Huang, Zhiwei ^b   Wu, Zhongming ^a   Chai, Jijie ^b   Zhong, Guangming ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES   (China)

Author keywords

Autoprocessing; Chlamydial infection; CPAF; Self activation; Serine protease

Indexed keywords

CHLAMYDIA SECREATED PROTEASOME LIKE ACTIVITY FACTOR; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; CELL LYSATE; CHLAMYDIA; CHLAMYDIASIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PURIFICATION; ENZYME RELEASE; ENZYME SUBSTRATE; HELA CELL; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; WILD TYPE;

AMINO ACID SUBSTITUTION; BACTERIAL PROTEINS; CHLAMYDIA TRACHOMATIS; HELA CELLS; HUMANS; MUTANT PROTEINS; MUTATION, MISSENSE; SERINE PROTEASES; VIRULENCE FACTORS;

CHLAMYDIA; MAMMALIA;

EID: 77955238246     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2010.05.008     Document Type: Article

References (36)

1. Grayston J.T., Wang S. New knowledge of chlamydiae and the diseases they cause. J Infect Dis 1975, 132:87-105.
2. Mabey D.C., Solomon A.W., Foster A. Trachoma. Lancet 2003, 362:223-229.
3. Vanrompay D., Harkinezhad T., van de Walle M., Beeckman D., van Droogenbroeck C., Verminnen K., et al. Chlamydophila psittaci transmission from pet birds to humans. Emerg Infect Dis 2007, 13:1108-1110.
4. Theegarten D., Sachse K., Mentrup B., Fey K., Hotzel H., Anhenn O. Chlamydophila spp. infection in horses with recurrent airway obstruction: similarities to human chronic obstructive disease. Respir Res 2008, 9:14.
5. Kauffold J., Melzer F., Berndt A., Hoffmann G., Hotzel H., Sachse K. Chlamydiae in oviducts and uteri of repeat breeder pigs. Theriogenology 2006, 66:1816-1823.
6. Stephens R.S. The cellular paradigm of chlamydial pathogenesis. Trends Microbiol 2003, 11:44-51.
7. Cheng W., Shivshankar P., Li Z., Chen L., Yeh I.T., Zhong G. Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection. Infect Immun 2008, 76:515-522.
8. Cheng W., Shivshankar P., Zhong Y., Chen D., Li Z., Zhong G. Intracellular interleukin-1alpha mediates interleukin-8 production induced by Chlamydia trachomatis infection via a mechanism independent of type I interleukin-1 receptor. Infect Immun 2008, 76:942-951.
9. Zhong G., Fan P., Ji H., Dong F., Huang Y. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med 2001, 193:935-942.
10. Dong F., Su H., Huang Y., Zhong Y., Zhong G. Cleavage of host keratin 8 by a Chlamydia-secreted protease. Infect Immun 2004, 72:3863-3868.
11. Kumar Y., Valdivia R.H. Actin and intermediate filaments stabilize the Chlamydia trachomatis vacuole by forming dynamic structural scaffolds. Cell Host Microbe 2008, 4:159-169.
12. Scidmore M. Chlamydia weave a protective cloak spun of actin and intermediate filaments. Cell Host Microbe 2008, 4:93-95.
13. Sun J., Schoborg R.V. The host adherens junction molecule nectin-1 is degraded by chlamydial protease-like activity factor (CPAF) in Chlamydia trachomatis-infected genital epithelial cells. Microbes Infect 2008.
14. Pirbhai M., Dong F., Zhong Y., Pan K.Z., Zhong G. The secreted protease factor CPAF is responsible for degrading pro-apoptotic BH3-only proteins in Chlamydia trachomatis-infected cells. J Biol Chem 2006, 281:31495-31501.
15. Dong F., Pirbhai M., Xiao Y., Zhong Y., Wu Y., Zhong G. Degradation of the proapoptotic proteins Bik, Puma, and Bim with Bcl-2 domain 3 homology in Chlamydia trachomatis-infected cells. Infect Immun 2005, 73:1861-1864.
16. Fischer S.F., Vier J., Kirschnek S., Klos A., Hess S., Ying S., et al. Chlamydia inhibit host cell apoptosis by degradation of proapoptotic BH3-only proteins. J Exp Med 2004, 200:905-916.
17. Zhong G., Fan T., Liu L. Chlamydia inhibits interferon gamma-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1. J Exp Med 1999, 189:1931-1938.
18. Zhong G., Liu L., Fan T., Fan P., Ji H. Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in chlamydia-infected cells. J Exp Med 2000, 191:1525-1534.
19. Dong F., Zhong Y., Arulanandam B., Zhong G. Production of a proteolytically active protein, chlamydial protease/proteasome-like activity factor, by five different Chlamydia species. Infect Immun 2005, 73:1868-1872.
20. Dong F., Pirbhai M., Zhong Y., Zhong G. Cleavage-dependent activation of a chlamydia-secreted protease. Mol Microbiol 2004, 52:1487-1494.
21. Dong F., Sharma J., Xiao Y., Zhong Y., Zhong G. Intramolecular dimerization is required for the chlamydia-secreted protease CPAF to degrade host transcriptional factors. Infect Immun 2004, 72:3869-3875.
22. Huang Z., Feng Y., Chen D., Wu X., Huang S., Wang X., et al. Structural basis for activation and inhibition of the secreted chlamydia protease CPAF. Cell Host Microbe 2008, 4:529-542.
23. Stephens R.S., Kalman S., Lammel C., Fan J., Marathe R., Aravind L., et al. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 1998, 282:754-759.
24. Goulding A., Shrestha S., Dria K., Hunt E., Deo S.K. Red fluorescent protein variants with incorporated non-natural amino acid analogues. Protein Eng Des Sel 2008, 21:101-106.
25. Muller-Taubenberger A., Anderson K.I. Recent advances using green and red fluorescent protein variants. Appl Microbiol Biotechnol 2007, 77:1-12.
26. Paschen S.A., Christian J.G., Vier J., Schmidt F., Walch A., Ojcius D.M., et al. Cytopathicity of Chlamydia is largely reproduced by expression of a single chlamydial protease. J Cell Biol 2008, 182:117-127.
27. Katoh I., Tomimori Y., Ikawa Y., Kurata S. Dimerization and processing of procaspase-9 by redox stress in mitochondria. J Biol Chem 2004, 279:15515-15523.
28. Salvesen G.S., Dixit V.M. Caspase activation: the induced-proximity model. Proc Natl Acad Sci U S A 1999, 96:10964-10967.
29. Sharma J., Bosnic A.M., Piper J.M., Zhong G. Human antibody responses to a Chlamydia-secreted protease factor. Infect Immun 2004, 72:7164-7171.
30. Heuer D., Brinkmann V., Meyer T.F., Szczepek A.J. Expression and translocation of chlamydial protease during acute and persistent infection of the epithelial HEp-2 cells with Chlamydophila (Chlamydia) pneumoniae. Cell Microbiol 2003, 5:315-322.
31. Lad S.P., Li J., daSilvaCorreia J., Pan Q., Gadwal S., Ulevitch R.J., et al. Cleavage of p65/RelA of the NF-kappaB pathway by Chlamydia. Proc Natl Acad Sci U S A 2007, 104:2933-2938.
32. Lad S.P., Yang G., Scott D.A., Wang G., Nair P., Mathison J., et al. Chlamydial CT441 is a PDZ domain-containing tail-specific protease that interferes with the NF-kappaB pathway of immune response. J Bacteriol 2007, 189:6619-6625.
33. Heuer D., Lipinski A.R., Machuy N., Karlas A., Wehrens A., Siedler F., et al. Chlamydia causes fragmentation of the golgi compartment to ensure reproduction. Nature 2008.
34. Greene W., Xiao Y., Huang Y., McClarty G., Zhong G. Chlamydia-infected cells continue to undergo mitosis and resist induction of apoptosis. Infect Immun 2004, 72:451-460.
35. Sharma J., Zhong Y., Dong F., Piper J.M., Wang G., Zhong G. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins. Infect Immun 2006, 74:1490-1499.
36. Zhong G., Reis e Sousa C., Germain R.N. Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein. Proc Natl Acad Sci U S A 1997, 94:13856-13861.